Ends Februar15th!
LAST NIGHT AT 11 NEWS 4 JAX CONSUMER INVESTIGATOR LAUREN VERNO’S TOOK AN IN-DEPTH LOOK
AT SOME OF YOUR CONCERNS ABOUT
THE COVID VACCINE IS IT
REALLY SAFE. WE ARE CONTINUING
THAT CONVERSATION THIS MORNING
SINCE WE KNOW MANY OF YOU HAVE
QUESTIONS ABOUT THE VACCINE.
DOCTOR ELIZABETH RANSOM FROM
BAPTIST HEALTH JOINS US THIS
MORNING TO ANSWER MORE OF THOSE
QUESTIONS DOCTOR
GOOD MORNING. ALWAYS GREAT TO
HAVE YOU ON THE SHOW GOOD
MORNING. THANK YOU GOOD TO
BE HERE. SO WE HAVE BEEN
HEARING ABOUT THIS VARIANT THAT
STARTED IN THE UNITED KINGDOM
HAS SPREAD HERE TO THE UNITED
STATES IN FACT, FLORIDA HAS THE
MOST REPORTS OF OF THIS
MUTATION INFECTING PEOPLE IN
OUR STATE. HOW DO WE KNOW FOR
CERTAIN THAT THE VACCINES THAT
ARE CURRENTLY ON THE MARKET
WILL PROTECT US FROM THE
VARIANT.
WELL THAT’S A GREAT
QUESTION. SO CURRENTLY THE UK
VARIANT IS AS YOU MENTIONED
BECOMING MORE PREVALENT IN THE
U.S..
>> THE MAIN RISK ASSOCIATED
WITH THAT PARTICULAR VARIANCE
IS THAT IT SEEMS TO BE MUCH
MORE
HIGHLY TRANSMISSIBLE. THAN THE
VIRUS THAT’S OUT THERE. IT DOES
NOT HOWEVER SEEM
TO BE. A CAUSE FOR WORSE OR
GREATER RISK OF. SIGNIFICANT
DISEASE
OR DEATH. THERE HAVE BEEN SOME
PRELIMINARY STUDIES THAT HAVE
LOOKED AT THE VACCINE’S
EFFECTIVENESS AGAINST THE UK
VARIANT AND IT DOES SEEM THAT
BOTH THE PFIZER AND MODERNA
VACCINES DO SEEM TO BE.
EFFECTIVE AGAINST THAT VARIANT.
THERE ARE OTHER VARIANCES SOUTH
AFRICA VARIANT, THERE’S NOW A
BRAZILIAN VARIANT
AS WELL. AND AND THE QUESTION
IS IF IF THE VIRUS IS AS
EFFECTIVE AGAINST VARIANCE AS
WELL GET THE VACCINE IS AND
THAT’S JUST A MATTER OF KIND OF
WAITING TO TO TO SEE.
>> I WANT TO TALK A LITTLE BIT
ABOUT
SIDE EFFECTS. AND I’M NOT
ASKING THESE FIRST 2 QUESTIONS
THAT I’VE ASKED BECAUSE I’M TRY
TO TALK PEOPLE OUT OF GETTING
THE VACCINE BY THE WAY BUT
THESE ARE THE QUESTIONS WE’RE
GETTING HERE AT THE STATION I
FEEL LIKE THEY DO NEED TO
BE ADDRESSED. SO SO IN TERMS OF
SIDE I’VE ACTUALLY
FAMILY MEMBERS AS WELL AS
NEIGHBORS WHO’VE BEEN WHO’VE
BEEN VACCINATED BECAUSE OF
THEIR AGE THEY’RE OVER 65 TO
HAVE ACTUALLY
GOTTEN SICK. YOU KNOW ONE WOMAN
TOLD ME THAT SHE WAS VOMITING
AFTER THE SECOND, YOU KNOW FOR
FOR A COUPLE OF HOURS AFTER THE
SECOND VACCINE. RECEIVING THE
SHOT AND THEN OTHERS HAVE
DESCRIBED KIND OF MILD FLULIKE
SYMPTOMS. IT IS
IS THAT COMMON SHOULD PEOPLE
GET THE VACCINE EXPECT THAT.
A FEW PEOPLE DO GET
AFTER THE VACCINATION GENERALLY
SYMPTOMS SEEM TO BE WORSE.
>> AFTER THE
SECOND DOSE. BUT SOME OF THOSE
SYMPTOMS CAN BE PAIN AT THE
INJECTION SITE SWELLING.
ALSO
FATIGUE HEADACHES. CHILLS AND
PEOPLE EVEN GET FEVERS
GENERALLY THE SYMPTOMS ARE SELF
LIMITED AND
ARE USUALLY KHAN WITHIN A
FEW DAYS.
>>JENNIFER WAUGH: SO GIVEN THAT
FOR ANYONE WHOM IS ON THE FENCE
ABOUT GETTING THE VACCINE AND
THEY HEAR SOMETHING LIKE THAT.
HOW DO YOU CONVINCE THEM THAT
IT’S IMPORTANT TO STILL
BE VACCINATED.
>> IT’S REALLY THOSE SYMPTOMS
ARE REALLY A SIGN OF YOUR
IMMUNE KICKING INTO AND
IT’S MUCH BETTER TO GET
SYMPTOMS RELATED TO
THE VACCINE THAN IT IS TO
ACTUALLY GET SYMPTOMS FROM THE
CORONAVIRUS
OR COVID.
>>JENNIFER WAUGH: SO WE KNOW
THAT JOHNSON JOHNSON’S VACCINE
IS EXPECTED TO ASK BASE.
WELL THAT COMPANY IS EXPECTED
TO ASK FOR APPROVAL FROM THE
FDA FOR ITS VACCINE BY THE END
OF
THE MONTH. YOU’VE GOT PFIZER
YOU’VE GOT MODERNA YOU’VE GOT
JOHNSON AND JOHNSON DO WE KNOW
WHAT THE DIFFERENCES BETWEEN
THE JOHNSON JOHNSON AND THE
OTHER 2 ON THE MARKET BECAUSE
SOME PEOPLE YOU KNOW YOU WONDER
IF THEY’RE GOING TO START
SHOPPING AROUND TO GET THAT THE
ONE THAT THEY FEEL MAYBE IS THE
MOST EFFECTIVE. WELL I I
>> THE EFFICACY CERTAINLY FOR PFIZER AND MODERNA ARE MID 90’S
9495%, EFFECTIVE. JOHNSON AND
ALSO LOOKS TO BE QUITE ALTHOUGH
WE DON’T HAVE TO THEN NUMBER
FOR
THAT YET IF THERE’S AN
AVAILABILITY TO GET A VACCINE.
WE ALL SHOULD TAKE THAT
OPPORTUNITY TO GET THE VACCINE
WHATEVER IS IS FIRST AVAILABLE
BECAUSE IT’S REALLY IMPORTANT
PARTICULARLY WITH SOME OF THESE
NEW MORE HIGHLY
TRANSMISSIBLE STRAINS. IT’S
IMPORTANT TO GET THAT
PROTECTION AS SOON AS POSSIBLE.
♪